vs

Side-by-side financial comparison of AstroNova, Inc. (ALOT) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.

Phathom Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($57.6M vs $39.2M, roughly 1.5× AstroNova, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs -3.4%). AstroNova, Inc. produced more free cash flow last quarter ($3.3M vs $-167.0M).

AstroNova, Inc. is a global technology firm designing, manufacturing and distributing specialty data visualization products, including high-performance label printers, test and measurement equipment, and aerospace-grade data recording systems, serving aerospace, manufacturing, retail and healthcare markets worldwide.

Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.

ALOT vs PHAT — Head-to-Head

Bigger by revenue
PHAT
PHAT
1.5× larger
PHAT
$57.6M
$39.2M
ALOT
Growing faster (revenue YoY)
PHAT
PHAT
+97.5% gap
PHAT
94.1%
-3.4%
ALOT
More free cash flow
ALOT
ALOT
$170.3M more FCF
ALOT
$3.3M
$-167.0M
PHAT

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
ALOT
ALOT
PHAT
PHAT
Revenue
$39.2M
$57.6M
Net Profit
$378.0K
Gross Margin
36.2%
86.7%
Operating Margin
3.3%
Net Margin
1.0%
Revenue YoY
-3.4%
94.1%
Net Profit YoY
221.5%
71.6%
EPS (diluted)
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALOT
ALOT
PHAT
PHAT
Q4 25
$39.2M
$57.6M
Q3 25
$36.1M
$49.5M
Q2 25
$37.7M
$39.5M
Q1 25
$28.5M
Q4 24
$40.4M
$29.7M
Q3 24
$40.5M
$16.4M
Q2 24
$33.0M
$7.3M
Q1 24
$39.6M
Net Profit
ALOT
ALOT
PHAT
PHAT
Q4 25
$378.0K
Q3 25
$-1.2M
$-30.0M
Q2 25
$-376.0K
$-75.8M
Q1 25
$-94.3M
Q4 24
$240.0K
Q3 24
$-311.0K
$-85.6M
Q2 24
$1.2M
$-91.4M
Q1 24
$2.7M
Gross Margin
ALOT
ALOT
PHAT
PHAT
Q4 25
36.2%
86.7%
Q3 25
32.2%
87.5%
Q2 25
33.6%
87.2%
Q1 25
86.9%
Q4 24
33.9%
87.1%
Q3 24
35.3%
85.6%
Q2 24
36.3%
81.2%
Q1 24
31.9%
Operating Margin
ALOT
ALOT
PHAT
PHAT
Q4 25
3.3%
Q3 25
-2.0%
-30.8%
Q2 25
1.5%
-151.7%
Q1 25
-276.5%
Q4 24
3.1%
Q3 24
2.6%
-433.0%
Q2 24
4.1%
-1055.4%
Q1 24
9.9%
Net Margin
ALOT
ALOT
PHAT
PHAT
Q4 25
1.0%
Q3 25
-3.4%
-60.5%
Q2 25
-1.0%
-191.9%
Q1 25
-330.7%
Q4 24
0.6%
Q3 24
-0.8%
-523.3%
Q2 24
3.6%
-1248.6%
Q1 24
6.8%
EPS (diluted)
ALOT
ALOT
PHAT
PHAT
Q4 25
$0.05
Q3 25
$-0.16
$-0.41
Q2 25
$-0.05
$-1.05
Q1 25
$-1.31
Q4 24
$0.03
Q3 24
$-0.04
$-1.32
Q2 24
$0.15
$-1.56
Q1 24
$0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALOT
ALOT
PHAT
PHAT
Cash + ST InvestmentsLiquidity on hand
$3.6M
$130.0M
Total DebtLower is stronger
$209.1M
Stockholders' EquityBook value
$76.9M
$-438.2M
Total Assets
$140.8M
$259.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALOT
ALOT
PHAT
PHAT
Q4 25
$3.6M
$130.0M
Q3 25
$3.9M
$135.2M
Q2 25
$5.4M
$149.6M
Q1 25
$212.3M
Q4 24
$4.4M
$297.3M
Q3 24
$4.8M
$334.7M
Q2 24
$4.0M
$276.2M
Q1 24
$4.5M
Total Debt
ALOT
ALOT
PHAT
PHAT
Q4 25
$209.1M
Q3 25
$207.1M
Q2 25
$205.1M
Q1 25
$203.2M
Q4 24
$201.4M
Q3 24
$175.7M
Q2 24
$174.4M
Q1 24
Stockholders' Equity
ALOT
ALOT
PHAT
PHAT
Q4 25
$76.9M
$-438.2M
Q3 25
$75.8M
$-422.5M
Q2 25
$76.6M
$-405.8M
Q1 25
$-338.4M
Q4 24
$92.2M
$-253.6M
Q3 24
$91.8M
$-187.1M
Q2 24
$91.2M
$-233.8M
Q1 24
$90.3M
Total Assets
ALOT
ALOT
PHAT
PHAT
Q4 25
$140.8M
$259.1M
Q3 25
$143.1M
$240.3M
Q2 25
$150.3M
$250.2M
Q1 25
$294.2M
Q4 24
$166.5M
$378.3M
Q3 24
$169.0M
$387.0M
Q2 24
$126.6M
$319.4M
Q1 24
$133.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALOT
ALOT
PHAT
PHAT
Operating Cash FlowLast quarter
$3.4M
$-166.8M
Free Cash FlowOCF − Capex
$3.3M
$-167.0M
FCF MarginFCF / Revenue
8.5%
-290.0%
Capex IntensityCapex / Revenue
0.2%
0.4%
Cash ConversionOCF / Net Profit
9.05×
TTM Free Cash FlowTrailing 4 quarters
$2.9M
$-328.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALOT
ALOT
PHAT
PHAT
Q4 25
$3.4M
$-166.8M
Q3 25
$249.0K
$-14.1M
Q2 25
$4.4M
$-62.7M
Q1 25
$-84.9M
Q4 24
$-4.7M
$-266.8M
Q3 24
$162.0K
$-63.6M
Q2 24
$6.9M
$-70.7M
Q1 24
$6.5M
Free Cash Flow
ALOT
ALOT
PHAT
PHAT
Q4 25
$3.3M
$-167.0M
Q3 25
$202.0K
$-14.1M
Q2 25
$4.3M
$-62.8M
Q1 25
$-84.9M
Q4 24
$-5.0M
$-266.9M
Q3 24
$-176.0K
$-63.6M
Q2 24
$6.4M
$-70.8M
Q1 24
$6.0M
FCF Margin
ALOT
ALOT
PHAT
PHAT
Q4 25
8.5%
-290.0%
Q3 25
0.6%
-28.6%
Q2 25
11.5%
-159.0%
Q1 25
-297.9%
Q4 24
-12.4%
-899.8%
Q3 24
-0.4%
-389.0%
Q2 24
19.5%
-966.2%
Q1 24
15.3%
Capex Intensity
ALOT
ALOT
PHAT
PHAT
Q4 25
0.2%
0.4%
Q3 25
0.1%
0.1%
Q2 25
0.2%
0.2%
Q1 25
0.1%
Q4 24
0.6%
0.5%
Q3 24
0.8%
0.3%
Q2 24
1.5%
0.6%
Q1 24
1.0%
Cash Conversion
ALOT
ALOT
PHAT
PHAT
Q4 25
9.05×
Q3 25
Q2 25
Q1 25
Q4 24
-19.76×
Q3 24
Q2 24
5.85×
Q1 24
2.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALOT
ALOT

Public Utilities Inventory Supplies$20.6M53%
Hardware Products$12.7M32%
Service And Other$5.9M15%

PHAT
PHAT

Segment breakdown not available.

Related Comparisons